180 related articles for article (PubMed ID: 19302565)
1. Low-dose combination therapy of severe digital ulcers in diffuse progressive systemic sclerosis with the endothelin-1 receptor antagonist bosentan and the phosphodiesterase V inhibitor sildenafil.
Ambach A; Seo W; Bonnekoh B; Gollnick H
J Dtsch Dermatol Ges; 2009 Oct; 7(10):888-91. PubMed ID: 19302565
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with an endothelin-1 receptor antagonist (bosentan) and a phosphodiesterase V inhibitor (sildenafil) for the management of severe digital ulcerations in systemic sclerosis.
Moinzadeh P; Hunzelmann N; Krieg T
J Am Acad Dermatol; 2011 Sep; 65(3):e102-e104. PubMed ID: 21839301
[No Abstract] [Full Text] [Related]
3. Bosentan and sildenafil: successful treatment in a sclerodermic patient with refractory ulcers.
Catarsi E; Doveri M; Tavoni A
Reumatismo; 2013 May; 65(2):79-81. PubMed ID: 23877412
[TBL] [Abstract][Full Text] [Related]
4. First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension.
Lunze K; Gilbert N; Mebus S; Miera O; Fehske W; Uhlemann F; Mühler EG; Ewert P; Lange PE; Berger F; Schulze-Neick I
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():32-8. PubMed ID: 16919008
[TBL] [Abstract][Full Text] [Related]
5. [Fast and efficient healing of scleroderma-associated acral ulcers with sildenafil].
Friedrichson E; Rehberger P; Fuhrmann JT; Walz F; Meurer M; Pfeiffer C
Hautarzt; 2008 Mar; 59(3):230-2. PubMed ID: 17618409
[TBL] [Abstract][Full Text] [Related]
6. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
Korn JH; Mayes M; Matucci Cerinic M; Rainisio M; Pope J; Hachulla E; Rich E; Carpentier P; Molitor J; Seibold JR; Hsu V; Guillevin L; Chatterjee S; Peter HH; Coppock J; Herrick A; Merkel PA; Simms R; Denton CP; Furst D; Nguyen N; Gaitonde M; Black C
Arthritis Rheum; 2004 Dec; 50(12):3985-93. PubMed ID: 15593188
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial.
Iversen K; Jensen AS; Jensen TV; Vejlstrup NG; Søndergaard L
Eur Heart J; 2010 May; 31(9):1124-31. PubMed ID: 20202971
[TBL] [Abstract][Full Text] [Related]
8. Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats.
Clozel M; Hess P; Rey M; Iglarz M; Binkert C; Qiu C
Exp Biol Med (Maywood); 2006 Jun; 231(6):967-73. PubMed ID: 16741032
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of systemic-sclerosis-related digital ulcers with a selective endothelin type A receptor antagonist (sitaxentan).
Gholam P; Sehr T; Enk A; Hartmann M
Dermatology; 2009; 219(2):171-3. PubMed ID: 19590168
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of combination therapy with bosentan and sildenafil for refractory pulmonary arterial hypertension associated with fibrotic lung in systemic sclerosis].
Gocho K; Sugino K; Ota H; Kusano E; Takai Y; Homma S
Nihon Kokyuki Gakkai Zasshi; 2010 Oct; 48(10):786-90. PubMed ID: 21066870
[TBL] [Abstract][Full Text] [Related]
11. [Systemic sclerosis: paths into the future].
Guillevin L
Presse Med; 2006 Dec; 35(12 Pt 2):1892-3. PubMed ID: 17159714
[No Abstract] [Full Text] [Related]
12. Oral sildenafil in skin ulcers secondary to systemic sclerosis.
Della Rossa A; Doveri M; D'Ascanio A; Tavoni A; Consensi A; Neri R; Bazzichi L; Bombardieri S
Scand J Rheumatol; 2011; 40(4):323-5. PubMed ID: 21639825
[No Abstract] [Full Text] [Related]
13. Effect of sildenafil on digital ulcers in systemic sclerosis: analysis from a single centre pilot study.
Brueckner CS; Becker MO; Kroencke T; Huscher D; Scherer HU; Worm M; Burmester G; Riemekasten G
Ann Rheum Dis; 2010 Aug; 69(8):1475-8. PubMed ID: 19900936
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with bosentan and phosphodiesterase-5 inhibitor in pulmonary arterial hypertension.
Morice AH; Mulrennan S; Clark A
Eur Respir J; 2005 Jul; 26(1):180; author reply 180-1. PubMed ID: 15994408
[No Abstract] [Full Text] [Related]
15. Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study.
Wilkins MR; Paul GA; Strange JW; Tunariu N; Gin-Sing W; Banya WA; Westwood MA; Stefanidis A; Ng LL; Pennell DJ; Mohiaddin RH; Nihoyannopoulos P; Gibbs JS
Am J Respir Crit Care Med; 2005 Jun; 171(11):1292-7. PubMed ID: 15750042
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of systemic sclerosis-related digital ulcers and sarcoidosis with endothelin receptor antagonist (bosentan) therapy.
Tillon J; Hervé F; Chevallier D; Muir JF; Levesque H; Marie I
Br J Dermatol; 2006 May; 154(5):1000-2. PubMed ID: 16634913
[No Abstract] [Full Text] [Related]
17. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
[TBL] [Abstract][Full Text] [Related]
18. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.
Matucci-Cerinic M; Denton CP; Furst DE; Mayes MD; Hsu VM; Carpentier P; Wigley FM; Black CM; Fessler BJ; Merkel PA; Pope JE; Sweiss NJ; Doyle MK; Hellmich B; Medsger TA; Morganti A; Kramer F; Korn JH; Seibold JR
Ann Rheum Dis; 2011 Jan; 70(1):32-8. PubMed ID: 20805294
[TBL] [Abstract][Full Text] [Related]
19. Bosentan for digital ulcers in patients with systemic sclerosis.
Nagai Y; Hasegawa M; Hattori T; Okada E; Tago O; Ishikawa O
J Dermatol; 2012 Jan; 39(1):48-51. PubMed ID: 21955007
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Bosentan in treatment of refractory sclerodermic bone prominences skin ulcers.
Richetta AG; Mattozzi C; Maiani E; D'Epiro S; Cimillio M; Carboni V; Giancristoforo S; Calvieri S
Clin Ter; 2008; 159(5):317-9. PubMed ID: 18998033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
